Cognitive Behavioural Therapies for Weight-Loss in Adults: A Scoping Review Protocol.
excess body weight
psychological intervention
weight loss
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
06 Sep 2023
06 Sep 2023
Historique:
received:
13
07
2023
revised:
20
08
2023
accepted:
04
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Obesity and being overweight are very important public health issues due to their increasing prevalence worldwide. Third-wave cognitive behavioural therapies (3wCBT) have emerged in the last few years to promote weight loss. However, the scientific evidence identifying the most commonly used 3wCBT in weight-loss interventions in adults is still needed. The objective of this scoping review will be to identify the most widely researched 3wCBT used to facilitate weight loss in an adult population who are overweight and obese, according to the published scientific literature. The search will be carried out independently by two authors in PubMed (MEDLINE), Scopus, EMBASE, Web of Science, and PsycINFO, using search equations that contain keywords related to our search question: (1) population: adult and elderly population, (2) intervention: terms related to 3wCBT, and (3) results: weight loss or weight management. The data extraction will be performed following the indications of the Cochrane manual, and the results will be presented in three tables. The 3wCBTs have shown promising results for weight loss, but it is not yet known which of them is the most widely used to achieve weight loss in the adult population. Thus, the results of this scoping review could guide professionals in the psychological treatment of obesity and being overweight.
Identifiants
pubmed: 37761670
pii: healthcare11182473
doi: 10.3390/healthcare11182473
pmc: PMC10531440
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Generalitat Valenciana
ID : AICO/2021/347
Références
JBI Evid Synth. 2020 Oct;18(10):2119-2126
pubmed: 33038124
Eur Heart J. 2022 Feb 22;43(8):716-799
pubmed: 35016208
Eat Weight Disord. 2021 Feb;26(1):191-199
pubmed: 31898239
Curr Diab Rep. 2022 Apr;22(4):157-168
pubmed: 35304703
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Clin Psychol Psychother. 2021 Jan;28(1):93-108
pubmed: 32515067
Eat Weight Disord. 2023 Feb 10;28(1):6
pubmed: 36763199
Clin Psychol Psychother. 2022 May;29(3):837-856
pubmed: 34802174
Qual Life Res. 2016 Feb;25(2):401-408
pubmed: 26216585
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):206-213
pubmed: 30003901
Int J Environ Res Public Health. 2023 Feb 03;20(3):
pubmed: 36768088
Behav Med. 2022 Jul-Sep;48(3):216-229
pubmed: 33052762
Curr Obes Rep. 2018 Mar;7(1):37-49
pubmed: 29446036
Obes Facts. 2017;10(6):666-673
pubmed: 29237167
Int J Environ Res Public Health. 2022 Dec 27;20(1):
pubmed: 36612767
Obes Rev. 2018 Feb;19(2):164-177
pubmed: 29076610
J Manag Care Spec Pharm. 2021 Mar;27(3):354-366
pubmed: 33470881
Obes Rev. 2020 Jul;21(7):e13013
pubmed: 32181957
Eat Weight Disord. 2016 Sep;21(3):477-485
pubmed: 26590601
Curr Opin Psychol. 2015 Apr;2:87-90
pubmed: 26101783
Front Endocrinol (Lausanne). 2022 Aug 26;13:772478
pubmed: 36093081
Metabolism. 2022 Aug;133:155217
pubmed: 35584732
Diabet Med. 2020 Feb;37(2):242-247
pubmed: 31901175
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Syst Rev. 2017 Dec 06;6(1):245
pubmed: 29208034
Health Sci Rep. 2023 Mar 27;6(3):e1157
pubmed: 36992714
BMC Med Res Methodol. 2018 Nov 19;18(1):143
pubmed: 30453902
World Psychiatry. 2021 Oct;20(3):363-375
pubmed: 34505370
Behav Ther. 2022 Jul;53(4):614-627
pubmed: 35697426
Front Immunol. 2022 Jul 04;13:907750
pubmed: 35860250
Health Qual Life Outcomes. 2022 Apr 19;20(1):63
pubmed: 35439997
Annu Rev Clin Psychol. 2011;7:141-68
pubmed: 21219193
Healthcare (Basel). 2023 Sep 06;11(18):
pubmed: 37761670
J Health Psychol. 2021 Sep;26(10):1700-1715
pubmed: 31804147
Front Neurosci. 2020 Aug 28;14:863
pubmed: 32982666
Behav Ther. 2016 Nov;47(6):869-885
pubmed: 27993338
Obes Surg. 2022 Sep;32(9):3041-3046
pubmed: 35819696
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Eur J Intern Med. 2021 Nov;93:3-7
pubmed: 33461826
Eur J Public Health. 2015 Apr;25(2):255-62
pubmed: 25320051
J Affect Disord. 2023 Jan 1;320:319-329
pubmed: 36183818
Front Endocrinol (Lausanne). 2021 Sep 06;12:706978
pubmed: 34552557
J Altern Complement Med. 2021 Nov;27(11):930-939
pubmed: 34252294
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30
pubmed: 36400097
Lancet. 2023 Apr 1;401(10382):1116-1130
pubmed: 36774932
Obes Rev. 2019 Feb;20(2):171-211
pubmed: 30324651
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Am J Public Health. 2016 Sep;106(9):1656-62
pubmed: 27459460
Diabetes Metab J. 2021 Nov;45(6):799-812
pubmed: 34847640
Obes Res Clin Pract. 2017 Sep - Oct;11(5 Suppl 1):90-111
pubmed: 27658995
Nat Rev Endocrinol. 2019 May;15(5):274-287
pubmed: 30655624